HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Recommendation Scrips For OTCs Grow In Popularity With German Doctors And Patients

Executive Summary

Germany's "grünes Rezept" recommendation prescription system for OTC medicines remains popular with the country's doctors and patients, according to new data from IQVIA.

You may also be interested in...

Germany Approves Trilogy Of Switches

Three prescription-to-OTC switches approved in Germany: Levocetirizine for oral use, diclofenac for use as a patch, and preparations containing sodium bituminosulfonate and hydrocortisone acetate.

Life’s An Itch And Then You Cry – New Hay Fever Products And Campaigns In Germany This Spring

New OTC products and campaigns for the hay fever season from: GSK, Novartis, Dermapharm, Galenpharma, DHU and Thea Pharma.

Apps and Recommendation Scrips Could Save UK's NHS £1.5bn A Year, Says PAGB

The Proprietary Association of Great Britain (PAGB) responds to the NHS Long Term Plan, suggesting that supporting self-care through health apps and recommendation prescriptions for OTCs could save the UK's health service over £1.5bn a year.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts